Role of diet in hyperuricemia and gout
- PMID: 34802900
- PMCID: PMC8678356
- DOI: 10.1016/j.berh.2021.101723
Role of diet in hyperuricemia and gout
Abstract
Background: Gout is the most common form of inflammatory arthritis, affecting 41 million adults worldwide. The global burden of gout has been increasing over the last three decades, yet its management remains suboptimal. The primary aim of this manuscript is to review the impact of various diets such as the DASH, Mediterranean, and low purine diets; weight loss; and individual foods, including alcohol, caffeine, cherry, dairy, high-fructose corn syrup, omega-3 fatty acids, and vitamin C on hyperuricemia and clinical gout outcomes such as flares and tophi.
Conclusion: Few studies to date have specifically evaluated the effect of various dietary approaches on hyperuricemia among people with gout and on gout-specific outcomes. Overall, the dietary factors appear to have a small effect on serum urate levels, and their impact on the long-term clinical course of gout is uncertain. Limited evidence suggests that avoidance of certain foods and beverages may decrease the frequency of gout flares. Weight loss may be beneficial for prevention as well as treatment of gout. Urate-lowering therapy remains the mainstay of therapy, with diet and dietary factors studied to date playing a limited role in the definitive management of gout.
Keywords: Body mass index; Diet; Dietary factors; Gout; Hyperuricemia.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
The Daniel K. Inouye College of Pharmacy Scripts: Perspectives on the Epidemiology of Gout and Hyperuricemia.Hawaii J Med Public Health. 2019 Feb;78(2):71-76. Hawaii J Med Public Health. 2019. PMID: 30766768 Free PMC article.
-
The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions.Int J Rheum Dis. 2012 Dec;15(6):499-506. doi: 10.1111/1756-185X.12010. Epub 2012 Oct 22. Int J Rheum Dis. 2012. PMID: 23253231 Review.
-
Environmental Triggers of Hyperuricemia and Gout.Rheum Dis Clin North Am. 2022 Nov;48(4):891-906. doi: 10.1016/j.rdc.2022.06.009. Rheum Dis Clin North Am. 2022. PMID: 36333002 Free PMC article. Review.
-
A perspective on diet and gout.Adv Chronic Kidney Dis. 2012 Nov;19(6):392-7. doi: 10.1053/j.ackd.2012.07.011. Adv Chronic Kidney Dis. 2012. PMID: 23089274 Review.
-
The role of diet in hyperuricemia and gout.Curr Opin Rheumatol. 2021 Mar 1;33(2):135-144. doi: 10.1097/BOR.0000000000000779. Curr Opin Rheumatol. 2021. PMID: 33399399 Free PMC article. Review.
Cited by
-
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement activation and inflammation modulators.Res Sq [Preprint]. 2024 May 9:rs.3.rs-4278877. doi: 10.21203/rs.3.rs-4278877/v1. Res Sq. 2024. Update in: Sci Rep. 2024 Oct 19;14(1):24598. doi: 10.1038/s41598-024-74154-5. PMID: 38766125 Free PMC article. Updated. Preprint.
-
Regulating Lipid Metabolism in Gout: A New Perspective with Therapeutic Potential.Int J Gen Med. 2024 Nov 12;17:5203-5217. doi: 10.2147/IJGM.S499413. eCollection 2024. Int J Gen Med. 2024. PMID: 39554874 Free PMC article. Review.
-
Innovative Formulation Platform: Paving the Way for Superior Protein Therapeutics with Enhanced Efficacy and Broadened Applications.Adv Mater. 2024 Oct;36(41):e2403116. doi: 10.1002/adma.202403116. Epub 2024 Jun 16. Adv Mater. 2024. PMID: 38819929 Free PMC article. Review.
-
Self-management behavior preferences and influencing factors in Chinese patients with recurrent gout: A qualitative study.Int J Nurs Sci. 2024 Oct 10;11(5):544-552. doi: 10.1016/j.ijnss.2024.10.001. eCollection 2024 Nov. Int J Nurs Sci. 2024. PMID: 39698134 Free PMC article.
-
Gut Microbiome Diversity and Uric Acid in Serum and Urine.Kidney Int Rep. 2025 Apr 3;10(6):1683-1693. doi: 10.1016/j.ekir.2025.03.040. eCollection 2025 Jun. Kidney Int Rep. 2025. PMID: 40630283 Free PMC article.
References
-
- DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–922. - PMC - PubMed
-
- Singh JA, Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3S):S11–S6. - PubMed
-
- Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007;57(1):109–15. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical